This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A triplet combination with Irinotecan (CPT-11) plu...
Clinical trial

A triplet combination with Irinotecan (CPT-11) plus Oxaliplatin (L-OHP), continuous infusion 5-fluorouracil (5-FU) and Leucovorin (LV) (FOLFOXIRI) plus Cetuximab (C-225) as first line treatment in metastatic colorectal cancer (MCC) : A pilot phase II tria

Read time: 1 mins
Last updated:23rd Feb 2007
The main objectives of this trial are to access the following: Objective Response Rate, Resectability Rates, Time to Tumor Progression (TTP), Median Overall Survival (mOS), Toxicity Profile, Pharmacogenomic Analysis, and Q-Twist analysis of Quality of Life.
Category Value
Study start date 2007-02-23

View full details